Literature DB >> 12875593

Management of the high-risk patient.

Victor G Vogel1.   

Abstract

Comprehensive breast cancer risk management is a practical tool that can now be regarded as a necessary clinical component of women's health. Risk assessment is the starting point for counseling women about risk, and it facilitates rational decision-making about prophylactic surgery, initiation of screening at an early age, and initiating preventive interventions. The availability of risk assessment models permit rapid risk calculation during routine clinical encounters, and risk profiles can be easily updated at subsequent clinical visits. Clinicians can now incorporate risk assessment and management into their routine screening and health maintenance appointments. Additional prospective clinical trials should be conducted to define the optimal use of existing management strategies, develop refined risk assessment instruments that incorporate additional risk-factor information, and evaluate populations for whom validated risk-assessment approaches do not yet exist.

Entities:  

Mesh:

Year:  2003        PMID: 12875593     DOI: 10.1016/S0039-6109(03)00030-6

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

1.  Assessing and managing breast cancer risk: clinical tools for advising patients.

Authors:  Bernard Friedenson
Journal:  MedGenMed       Date:  2004-01-14

2.  Lymphocyte subsets predictive value and possible involvement of human papilloma virus infection on breast cancer molecular subtypes.

Authors:  Andreína Fernandes; Adriana Pesci-Feltri; Isabel García-Fleury; Marco López; Vincent Guida; Marisol De Macedo; María Correnti
Journal:  World J Clin Oncol       Date:  2018-11-10

3.  Development of a personalized decision aid for breast cancer risk reduction and management.

Authors:  Elissa M Ozanne; Rebecca Howe; Zehra Omer; Laura J Esserman
Journal:  BMC Med Inform Decis Mak       Date:  2014-01-14       Impact factor: 2.796

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.